Logo image
Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay
Journal article   Peer reviewed

Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay

M. Jones, A.H. Peden, D. Wight, C. Prowse, I. MacGregor, J. Manson, M. Turner, J.W. Ironside and M.W. Head
Neuroreport, Vol.19(18), pp.1783-1786
2008
url
Link to Published Version *Subscription may be requiredView

Abstract

Prion protein type and codon 129 genotype are thought to be major determinants of susceptibility and phenotype in human prion diseases. Using an in-vitro system (protein misfolding cyclic amplification) we have attempted to model human prion protein conversion using the abnormal prion protein associated with each of the major sporadic Creutzfeldt–Jakob disease subtypes, in substrates containing the normal cellular form of the prion protein of each of the three possible human PRNP codon 129 polymorphic genotypes. The prion protein type is converted with fidelity in these amplification reactions, but the efficiency of conversion depends both on the methionine/valine polymorphic status of the sporadic Creutzfeldt–Jakob disease seed and substrate homogenate, and on the abnormal prion protein type.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.992 Prion Pathogenesis
Web Of Science research areas
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image